PMID- 12559634 OWN - NLM STAT- MEDLINE DCOM- 20030926 LR - 20191210 IS - 0198-8859 (Print) IS - 0198-8859 (Linking) VI - 64 IP - 2 DP - 2003 Feb TI - TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. PG - 302-9 AB - The human leukocyte antigen (HLA) class III region, located on chromosome 6p21, has been regarded as one of the susceptible loci for type 1 diabetes. Because it contains many genes related to inflammatory and immune responses, including tumor necrosis factor (TNF), lymphotoxin-alpha (LT-alpha), and allograft inflammatory factor 1 (AIF-1) genes, it is unclear which gene within the class III region is responsible for the susceptibility to the disease. We sequenced the AIF-1 gene region and detected three novel polymorphisms, all of which were diallelic and localized at introns. Then, we investigated AIF-1, TNF, and LT-alpha gene polymorphisms in 165 patients with type 1 diabetes, consisting of 90 patients with young-onset type 1 diabetes, 75 patients with adult-onset type 1 diabetes, and 200 control patients. We also analyzed TNF receptors type 1 (TNFR1) and type 2 (TNFR2) gene polymorphisms, located on chromosome 12p13 and 1p36, respectively. Although there were significant differences between type 1 diabetes patients and controls in the distributions of TNF promoter polymorphisms at position -1031 and -857, and LT-alpha gene NcoI polymorphism, none of them was independently associated with the disease after two-locus analysis with HLA class II alleles. We detected the significantly increased frequency of the -383C allele, located in the TNFR-1 promoter region, in both young-onset and adult-onset diabetes patients compared with controls. In addition, the -383C allele was found to be associated with higher expression of the TNFR1 gene than that of -383A allele in in vitro expression. These results suggest that the TNFR1 gene region might be a susceptible locus to type 1 diabetes in Japanese. FAU - Nishimura, Masataka AU - Nishimura M AD - Department of the Clinical Neuroscience, Tokushima University Hospital, Japan. m_nishim@clin.med.tokushima-u.ac.jp FAU - Obayashi, Hiroshi AU - Obayashi H FAU - Mizuta, Ikuko AU - Mizuta I FAU - Hara, Hirokazu AU - Hara H FAU - Adachi, Tetsuo AU - Adachi T FAU - Ohta, Mitsuhiro AU - Ohta M FAU - Tegoshi, Hisataka AU - Tegoshi H FAU - Fukui, Michiaki AU - Fukui M FAU - Hasegawa, Goji AU - Hasegawa G FAU - Shigeta, Hirofumi AU - Shigeta H FAU - Kitagawa, Yoshihiro AU - Kitagawa Y FAU - Nakano, Koji AU - Nakano K FAU - Kaji, Ryuji AU - Kaji R FAU - Nakamura, Naoto AU - Nakamura N LA - eng PT - Journal Article PL - United States TA - Hum Immunol JT - Human immunology JID - 8010936 RN - 0 (AIF1 protein, human) RN - 0 (Antigens, CD) RN - 0 (Calcium-Binding Proteins) RN - 0 (DNA-Binding Proteins) RN - 0 (Lymphotoxin-alpha) RN - 0 (Microfilament Proteins) RN - 0 (Receptors, Tumor Necrosis Factor) RN - 0 (Receptors, Tumor Necrosis Factor, Type I) RN - 0 (Receptors, Tumor Necrosis Factor, Type II) RN - 0 (Tumor Necrosis Factor-alpha) SB - IM MH - Adult MH - Age of Onset MH - Antigens, CD/*genetics MH - Autoimmune Diseases/*genetics MH - Calcium-Binding Proteins/*genetics MH - Child MH - Chromosomes, Human, Pair 1/genetics MH - Chromosomes, Human, Pair 12/genetics MH - Chromosomes, Human, Pair 6/*genetics MH - DNA-Binding Proteins MH - Diabetes Mellitus, Type 1/epidemiology/*genetics MH - Gene Frequency MH - Genetic Linkage MH - Genetic Predisposition to Disease MH - Genotype MH - HeLa Cells MH - Humans MH - Japan/epidemiology MH - Lymphotoxin-alpha/genetics MH - Microfilament Proteins MH - *Polymorphism, Genetic MH - Promoter Regions, Genetic/genetics MH - Receptors, Tumor Necrosis Factor/*genetics MH - Receptors, Tumor Necrosis Factor, Type I MH - Receptors, Tumor Necrosis Factor, Type II MH - Transcription, Genetic MH - Transfection MH - Tumor Necrosis Factor-alpha/*genetics EDAT- 2003/02/01 04:00 MHDA- 2003/09/27 05:00 CRDT- 2003/02/01 04:00 PHST- 2003/02/01 04:00 [pubmed] PHST- 2003/09/27 05:00 [medline] PHST- 2003/02/01 04:00 [entrez] AID - S0198885902007991 [pii] AID - 10.1016/s0198-8859(02)00799-1 [doi] PST - ppublish SO - Hum Immunol. 2003 Feb;64(2):302-9. doi: 10.1016/s0198-8859(02)00799-1.